Opinion
No. 15-3475
09-29-2016
IN RE: MODAFINIL ANTITRUST LITIGATION Mylan Laboratories, Inc.; Mylan Pharmaceuticals Inc.; Ranbaxy Laboratories, Ltd; Ranbaxy Pharmaceuticals, Inc., Appellants
On Appeal from the United States District Court for the Eastern District of Pennsylvania
District Court No. 2-06-cv-01797
District Judge: The Honorable Mitchell S. Goldberg Before: SMITH, JORDAN, and RENDELL, Circuit Judges ORDER AMENDING OPINION
The opinion filed September 13, 2016 is amended solely as to the listing of Paul B. Hewitt, Esq. and Catherine Creely, Esq. on the opinion and not as to the substance of the opinion itself. Mr. Hewitt and Ms. Creely should have been listed as members of Akin Gump Strauss Hauer & Feld in Washington, DC. Mr. Hewitt was omitted from the listing of counsel and Ms. Creely was erroneously listed as a member of Cohn & Marks in Washington, DC. The opinion is amended as follows: Paul B. Hewitt
C. Fairley Spillman
Catherine E. Creely
Akin Gump Strauss Hauer & Feld
1333 New Hampshire Avenue, N.W.
Suite 400
Washington, DC 20036 For the Court, /s/
Marcia M. Waldron, Clerk
Date: September 29, 2016
PDB/cc: All Counsel of Record